Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma

作者：Zou, Song; Wang, Chen; Liu, Jiansheng; Wang, Qun; Zhang, Dongdong; Zhu, Shengnan; Xu, Shengyuan; Kang, Mafei; He, Shaozhong^*

来源：Molecules and Cells, 2017, 40(11): 847-854.

DOI：10.14348/molcells.2017.0129

• cancer stem cells (CSCs)
• hepatocellular carcinoma (HCC)
• Sox12

Recent studies on molecular carcinogenesis suggest that the chemo-resistance of some cancers is largely due to presence of cancer stem cells (CSCs), which affect the chemotherapy outcome for hepatocellular carcinoma (HCC). However, currently no consensus on a CSC phenotype in HCC has been obtained. Here, we examined Sox12 as a novel CSC marker in HCC. Sox12+ versus Sox12- cells were purified from HCC cell lines. The Sox12+ cells were compared with Sox12- HCC cells for tumor sphere formation, chemo-resistance, tumor formation after serial adoptive transplantations in nude mice, and the frequency of developing distal metastasis. We found that compared to Sox12- HCC cells, Sox12+ HCC cells generated significantly more tumor spheres in culture, were more chemo-resistant to cisplatin, were detected in circulation more frequently, and formed distal tumor more frequently. Moreover, Sox12 appeared to functionally contribute to the stemness of HCC cells. Thus, we conclude that Sox12 may be a novel marker for enriching CSCs in HCC.

• 出版日期2017-11
• 单位桂林医学院